Table 3.
Haplotypes | Control* (%) | LSIL* (%) | χ2 | P | OR† (95% CI) | HSIL* (%) | χ2 | P | OR‡ (95% CI) |
ATCCGGGG | 30.8 | 45.6 | 15.97 | 6.43e - 05 | 4.36 (3.09–6.15) | 34.0 | 2.93 | 0.0867 | — |
GTCCGGGG | 15.3 | 7.9 | 8.74 | 0.0031 | — | 13.5 | 2.33 | 0.1263 | — |
ATCTGGGG | 15.1 | 4.5 | 20.27 | 6.70e - 06 | 0.39 (0.21–0.70) | 8.5 | 1.02 | 0.3122 | — |
ATACGGGG | 7.3 | 1.0 | 13.50 | 2.00e - 04 | 0.19 (0.06–0.59) | 16.2 | 30.10 | 4.09e - 08 | 2.43 (1.26–4.69) |
GTCTGGGG | 6.7 | 25.4 | 50.99 | 9.26e - 13 | 8.33 (5.12–13.61) | 21.1 | 0.19 | 0.6626 | 3.85 (2.05–7.23) |
ACCCGGGG | 5.6 | 6.4 | 0.22 | 0.6363 | — | 1.7 | 5.37 | 0.0204 | — |
GCCCGGGG | 4.4 | 0.0 | 12.55 | 4.00e - 04 | — | 0.0 | 4.77 | 0.0289 | — |
GTCCGAGG | 3.9 | 0.0 | 10.83 | 0.001 | — | 1.7 | 0.05 | 0.8133 | — |
ACACGGGG | 2.2 | 3.9 | 1.61 | 0.2041 | 2.68 (1.09–6.75) | 0.0 | 5.80 | 0.016 | — |
ACCTGGGG | 2.0 | 0.0 | 5.34 | 0.0208 | — | 0.0 | 2.16 | 0.1415 | — |
ACACAAGG§ | 0.0 | 2.7 | 10.98 | 9.00e - 04 | — | 0.0 | — | — | — |
Frequency of haplotype.
Comparison between the LSIL and control groups; all significant data are shown (P < .05).
Comparison between the HSIL and control groups; all significant data are shown (P < .05).
Haplotype only found in patients with LSIL.